Kenichi Furihata

1PUBLICATIONS
5CO-AUTHORS
Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 11, 2025
Japanese Phase 1 Study for Global Development of Anti-TL1A Antibody PF-06480605: A Randomized, Placebo-Controlled, Single-Ascending Dose Study.

Kei Fukuhara, Srividya Neelakantan, Kenichi Furihata

Pageof 1

Frequent Collaborators

1 joint publications

Kei Fukuhara

1 joint publications

Srividya Neelakantan

1 joint publications

Hirotoshi Yuasa

1 joint publications

Nanzhi Shi